The HUSERMET project was funded in 2005 through the "Link Scheme in Applied Genomics" initiative by the BBSRC and MRC and the DTI. It was a collaboration between The University of Manchester, GlaxoSmithKline and AstraZeneca.
The HUSERMET project involved three key studies:
Since biological samples are very complex, containing thousands of compounds at different concentrations, the HUSERMET project required methods designed to maximise the number of compounds detected.
Volunteers were recruited with the assistance of: